AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
AMLODIPINE BESYLATE + VALSARTAN
18 registrations across 3 African markets— 18 active
Markets with AMLODIPINE BESYLATE + VALSARTAN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| AMSTAN TABLETS (Each film coated tablet contains Amlodipine Besylate/Valsartan 5mg/160mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| AMSTAN TABLETS (Each tablet contains Amlodipine Besylate/Valsartan 5mg/80mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| AMSTAN TABLETS (Each tablet contains Amlodipine Besylate/Valsartan 5mg/80mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| AMSTAN TABLETS (Each film coated tablet contains Amlodipine Besylate/Valsartan 5mg/160mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| EXFORGE 10/160 TABLET | 🇬🇭Ghana | NORVATIS PHARMA GHANA LIMITED, ANYISA BUILDING LIMITED ESTATES OSU PMB OS 89 GREATER ACCRA | active | Dec 2029 |
| EXFORGE 10/160 TABLET | 🇬🇭Ghana | NORVATIS PHARMA GHANA LIMITED, ANYISA BUILDING LIMITED ESTATES OSU PMB OS 89 GREATER ACCRA | active | Dec 2029 |
| EXFORGE TABLET, COATED; ORAL | 🇿🇼Zimbabwe | NOVARTIS PHARMACEUTICAL CORPORATION | active | Dec 2027 |
| EXFORGE TABLET, COATED; ORAL | 🇿🇼Zimbabwe | NOVARTIS PHARMACEUTICAL CORPORATION | active | Dec 2027 |
| EXFORGE TABLET, COATED; ORAL | 🇿🇼Zimbabwe | NOVARTIS PHARMACEUTICAL CORPORATION | active | Dec 2027 |
| VALPLUS 10+ TABLET, COATED; ORAL | 🇿🇼Zimbabwe | KARLADE GLOBAL DMCC | active | Dec 2027 |
| AMLODIPINE
BESYLATE +
VALSARTAN ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | MACLEODS PHARMACEUTICA LS LTD | active | — |
| AMLODIPINE
BESYLATE +
VALSARTAN ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | UNITED PHARMACEUTICA L MANUFACTURIN G COMPANY LIMITED | active | — |
| AMLODIPINE
BESYLATE +
VALSARTAN ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | MACLEODS PHARMACEUTICA LS LTD | active | — |
| AMLODIPINE
BESYLATE +
VALSARTAN ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | UNITED PHARMACEUTICA L MANUFACTURIN G COMPANY LIMITED | active | — |
| AMLODIPINE
BESYLATE +
VALSARTAN ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | MACLEODS PHARMACEUTICA LS LTD | active | — |
| AMLODIPINE
BESYLATE +
VALSARTAN ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | MACLEODS PHARMACEUTICA LS LTD | active | — |
| AMLODIPINE
BESYLATE +
VALSARTAN ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | UNITED PHARMACEUTICA L MANUFACTURIN G COMPANY LIMITED | active | — |
| AMLODIPINE
BESYLATE +
VALSARTAN ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | UNITED PHARMACEUTICA L MANUFACTURIN G COMPANY LIMITED | active | — |
AMLODIPINE BESYLATE + VALSARTAN in Africa — Regulatory Overview
AMLODIPINE BESYLATE + VALSARTAN is registered across 3 African markets with 18 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Ghana, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.
Of the 18 registrations, 18 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.